CHRISTIANA KEKE-EKEKWE: Open Payments
NPI 1811285075 · LANHAM, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$311 in 7 payments from 4 companies in 2025. Trend: 2023 $407 · 2024 $61 · 2025 $311
Food & beverage: $311
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $114 |
| Abbott Laboratories | 1 | $97 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 |
| Amgen Inc. | 2 | $43 |
Products named: INGREZZA, FREESTYLE LIBRE 3, REPATHA, UZEDY, AUSTEDO XR.
Industry payments across MD — which companies pay providers there.
